Representative Literature References

Click a row to open its literature reference.

Product

Separation Mode

Broad Sample Type

Specific Sample

Year

Product

Sep. Mode

Broad Sample Category

Specific Sample

Title

2024	Unix-C SEC-300	231300-4615	SEC	Antibody	HIV-1 Env Antibody	Absolute quantitation of binding antibodies from clinical samples
2023	Proteomix HIC Butyl-NP5	N/A	HIC	Antibody	MAb	Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
2022	SRT-10C SEC-300	239300-30030	SEC	Antibody	mAb	Development of a robust and semi-automated two-step antibody purification process Mabs. Vol. 13. No. 1. Taylor & Francis, 2021.
2021	SRT SEC-500	215500-4630	SEC	Antibody	IgG	Comparative Analysis of Antibodies and Heavily Glycosylated Macromolecular Immune Complexes by Size-Exclusion Chromatography Multi-Angle Light Scattering, Native Charge Detection Mass Spectrometry, and Mass Photometry Analytical Chemistry (2021).
2021	Proteomix SCX-NP10, Antibodix WCX-NP5	401NP10-4625, 401NP10-10025, 401NP10-21225, 401NP10-10005, 602NP5-4625	IEX	Antibody	Human IgG1 Mab	A novel twin-column continuous chromatography approach for separation and enrichment of monoclonal antibody charge variants Engineering in Life Sciences Volume21, Issue 6 June 2021 Pages 382-391
2020	Proteomix HIC butyl-NP5	431NP5-4603	HIC	Antibody	mAb	An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19 bioRxiv (2020).
2020	Proteomix SCX-NP5	401NP5-4610	IEX	Antibody	ABF710	Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product Saleem, Ramsey, et al. "Analytical and functional similarity assessment of ABP 710, a biosimilar to infliximab reference product." Pharmaceutical research 37.6 (2020): 1-23.
2020	Proteomix SCX NP5	401NP5-4610	IEX	Antibody	infliximab	Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product Pharmaceutical research 37.6 (2020): 1-23.
2020	Proteomix SCX-NP5, PEEK	401NP5P-4625	IEX	Antibody	IgG2 isoforms	Optimizing TNFR2 antagonism for immunotherapy with tumor microenvironment specificity Journal of Leukocyte Biology Volume 107, Issue 6 June 2020 Pages 971-980
2020	SRT-10C SEC-100	239100-10030	SEC	Antibody	Synthetic nanobodies	Generation of synthetic nanobodies against delicate proteins Nature Protocols volume 15, pages1707–1741 (2020)
2019	Proteomix HIC butyl-NP5	431NP5-4603	HIC	Antibody	mAbs with Vκ or Vλ variability	Affinity Maturation Enhances Antibody Specificity but Compromises Conformational Stability Cell reports 28.13 (2019): 3300-3308.
2018	SRT SEC-500	215500-4630	SEC	Antibody	α4β2–Fab complexes	Structural principles of distinct assemblies of the human α4β2 nicotinic receptor Nature volume 557, pages261–265 (2018)
2018	SRT-C SEC-300	235300-4630	SEC	Antibody	Antibody	Mobile Affinity Sorbent Chromatography Anal. Chem. 2018, 90, 3, 1668–1676
2018	Zenix-C SEC-300	N/A	SEC	Antibody	N/A	A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases The Journal of Biological Chemistry 293, 9326-9334. 10.1074/jbc.M117.818559
2018	Zenix SEC-300	N/A	SEC	Antibody	N/A	An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E PLOS ONE 13(5): e0197011. https://doi.org/10.1371/journal.pone.0197011
2018	N/A	N/A	IEX	Antibody	N/A	Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates mAbs. 2018;10(4):583-595. doi:10.1080/19420862.2018.1440165.
2017	Zenix SEC-300 & Proteomix HIC butyl-NP5	213300-4630, 431NP5-4603	SEC	Antibody	IgG	Biophysical properties of the clinical-stage antibody landscape Proceedings of the National Academy of Sciences 114.5 (2017): 944-949.
2017	Proteomix HIC butyl-NP5	431NP5-4603	HIC	Antibody	mAbs	Prediction of Delayed Retention of Antibodies in Hydrophobic Interaction Chromatography from Sequence using Machine Learning Bioinformatics 33.23 (2017): 3758-3766.
2017	N/A	N/A	IEX	Antibody	N/A	On-Line Ion Exchange Liquid Chromatography as a Process Analytical Technology for Monoclonal Antibody Characterization in Continuous Bioprocessing Anal. Chem. 89, 21, 11357-11365
2017	N/A	N/A	IEX	Antibody	N/A	Preclinical Characterization of CTL-1, A Biosimilar Anti-EGFR Monoclonal Antibody for Cetuximab SM J Bioequiv Availab 1, no. 1 (2017): 1003.
2017	Zenix-C SEC-300	N/A	SEC	Antibody	N/A	Efficient generation of single domain antibodies with high affinities and enhanced thermal stabilities Scientific Reports 7, Article number: 5794 (2017) doi:10.1038/s41598-017-06277-x
2016	Zenix SEC-300	N/A	SEC	Antibody	N/A	Analysis of monoclonal antibody oxidation by simple mixed mode chromatography Journal of Chromatography A Volume 1431, 29 January 2016, Pages 154–165
2016	Zenix SEC-300	N/A	SEC	Antibody	N/A	Immunotargeting of Integrin α6β4 for Single-Photon Emission Computed Tomography and Near-Infrared Fluorescence Imaging in a Pancreatic Cancer Model Molecular Imaging January-December 2016 vol. 15 1536012115624917
2015	Zenix SEC-300	N/A	SEC	Antibody	mAbs of 12 varieties	A novel screening method to assess developability of antibody-like molecules
2015	Zenix-C SEC-300	N/A	SEC	Antibody	N/A	Intrinsic fluorescence-based at situ soft sensor for monitoring monoclonal antibody aggregation Biotechnology Progress
2014	Zenix SEC-300	N/A	SEC	Antibody	N/A	Antitumor efficacy of a bispecific antibody that targets HER2 and activates T cells. Cancer Res. 2014 Oct 1;74(19):5561-71. doi: 10.1158/0008-5472.CAN-13-3622-T.
2012	Zenix SEC-300	N/A	SEC	Antibody	N/A	Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system mAbs, Volume 4, Issue 2, pages 217-225
2011	Zenix SEC-300	N/A	SEC	Antibody	N/A	Antibody solubility behavior in monovalent salt solutions reveals specific anion effects at low ionic strength Journal of Pharmaceutical Sciences, Volume 101, Issue 3, pages 965-977

Products | Privacy Policy | Career | Contact Us

By Separation Mode	By Brand	By Sample Based Application
Size Exclusion Ion Exchange Hydrophobic Interaction Ion Exclusion Sub-2 UHPLC Purification Reversed Phase Mixed-mode Phase HILIC View All	SEC-MALS Unix / Unix-C Zenix / Zenix-C SRT / SRT-C SRT-10 / SRT-10C Proteomix HIC / IEX Antibodix Carbomix Proteomix RP View All	ADC Antibody Biosimilar Carbohydrate Cell Lysate DNA/RNA Fusion Protein Glycan Glycoprotein Heparin	Insulin Membrane Protein Organic Acid PEG/PEGylated Protein Peptide Polymer Protein Vaccine/VLP Others